Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Gain Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q1 2025
- Shares held
- 3.79M
- +977.2K (+34.8%) vs. Q1 2025
- Total value
- $6.49M
- +$1.42M (+28.1%) vs. Q1 2025
- New holders
- 6
- 11 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $17.4M |
| Q1 2026 | 42 | $15.8M |
| Q4 2025 | 48 | $25.9M |
| Q3 2025 | 38 | $7.70M |
| Q2 2025 | 35 | $6.49M |
| Q1 2025 | 33 | $5.07M |
| Q4 2024 | 25 | $3.94M |
| Q3 2024 | 19 | $2.40M |
| Q2 2024 | 28 | $3.89M |
| Q1 2024 | 26 | $7.04M |
| Q4 2023 | 24 | $5.05M |
| Q3 2023 | 24 | $4.95M |
| Q2 2023 | 24 | $5.68M |
| Q1 2023 | 22 | $5.54M |
| Q4 2022 | 21 | $3.78M |
| Q3 2022 | 23 | $3.95M |
| Q2 2022 | 16 | $3.87M |
| Q1 2022 | 16 | $4.75M |
| Q4 2021 | 19 | $5.71M |
| Q3 2021 | 14 | $6.65M |
| Q2 2021 | 14 | $8.95M |
| Q1 2021 | 12 | $15.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 945 | $1.70K | 0.00% | −1,487−61.1% | Reduced |
| State of Wyoming | 1,194 | $2.15K | 0.00% | +1,194 | New |
| Raymond James Financial Inc | 2,300 | $4.14K | 0.00% | +2,300 | New |
| SRS Capital Advisors, Inc. | 2,500 | $4.50K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,650 | $4.77K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,164 | $7.50K | 0.00% | +62+1.5% | Added |
| MAI Capital Management | 4,410 | $7.94K | 0.00% | 00.0% | Unchanged |
| Creekmur Asset Management LLC | 4,440 | $7.99K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,657 | $10.0K | 0.00% | +2,213+64.3% | Added |
| Group One Trading, L.P. | 6,401 | $11.5K | 0.00% | +6,401 | New |
| Armis Advisers, LLC | 10,750 | $18.6K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 10,600 | $19.1K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 12,756 | $23.0K | 0.00% | +12,756 | New |
| Sandhill Capital Partners LLC | 15,400 | $27.7K | 0.00% | 00.0% | Unchanged |
| Benedict Financial Advisors Inc | 22,500 | $40.5K | 0.01% | +4,500+25.0% | Added |
| Virtu Financial LLC | 23,801 | $43.0K | 0.00% | +23,801 | New |
| Bridgeway Capital Management, LLC | 30,004 | $54.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 32,635 | $58.7K | 0.00% | −10,725−24.7% | Reduced |
| Prelude Capital Management, LLC | 35,820 | $64.5K | 0.01% | 00.0% | Unchanged |
| Dauntless Investment Group, LLC | 46,000 | $82.8K | 0.39% | −79,584−63.4% | Reduced |
| Kovitz Investment Group Partners, LLC | 47,578 | $85.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 71,137 | $128.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 76,512 | $137.7K | 0.00% | −23,283−23.3% | Reduced |
| Susquehanna International Group, LLP | 79,551 | $143.2K | 0.00% | −6,407−7.5% | Reduced |
| Renaissance Technologies LLC | 94,000 | $169.2K | 0.00% | +94,000 | New |
| Northern Trust Corp | 100,170 | $180.3K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 112,507 | $202.5K | 0.00% | +28,100+33.3% | Added |
| Citadel Advisors LLC | 161,816 | $291.3K | 0.00% | +142,797+750.8% | Added |
| Cambridge Investment Research Advisors, Inc. | 179,500 | $323.0K | 0.00% | +120,000+201.7% | Added |
| Marshall Wace, LLP | 276,433 | $497.6K | 0.00% | +80,407+41.0% | Added |
| Geode Capital Management, LLC | 290,462 | $522.9K | 0.00% | +8,251+2.9% | Added |
| Vanguard Group Inc | 534,352 | $961.8K | 0.00% | +279,362+109.6% | Added |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 566,130 | $1.02M | 0.04% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 676,888 | $1.33M | 0.00% | +249,188+58.3% | Added |
| Gotham Asset Management, LLC | 245,896 | – | – | +91,912+59.7% | Added |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −20,154−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,355−100.0% | Sold out |
| Sprott Inc. | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |